The Song Remains the Same: Exploring the Intersection of U.S. Export Controls and Life Sciences Companies

Over the past few months, much has been written about the expansive U.S. sanctions against Russia and Belarus. At the same time, there are indications that other sanctions programs may be loosened. Export control regulators are spending a lot of energy on compliance investigations. Please join Michael E. Burke, Corporate partner and co-chair of the Pharmaceuticals & Medical Devices team, and Alan G. Minsk, partner, leader of the Food & Drug team, and co-chair of the Pharmaceuticals & Medical Devices team, for a complimentary webinar focusing on considerations related to export controls and trade sanctions.

This webinar will focus on a variety of topics, including:
• a discussion on how life sciences companies are affected by U.S. export controls and
• how those companies can develop a specific and nimble export controls compliance program.

There will be an opportunity for Q&A at the end of this webinar.

Credits: 1 hour of CLE credit is pending approval by the State Bar of Georgia.